Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Lophius Biosciences appoints co-CEO to drive growth

This article was originally published in Clinica

Executive Summary

Lophius Biosciences, a specialist in T cell-based research tools and diagnostics for functional assessment of pathogen/disease-reactive T cells, has appointed Bernd Merkl co-CEO. He was formerly the site and product management leader of Thermo Fisher Scientific’s GeneArt Centre of Excellence for Synthetic Biology. Working alongside Regensburg, Germany-based Lophius’ current CEO, Robert Phelps, Merkl will focus on the commercial operations including all marketing and sales activities. Lophius’ flagship product is T-Track CMV, a diagnostic system intended to determine the functionality of the cell-mediated immune response in cytomegalovirus seropositive transplant patients who undergo an immunosuppressive therapy.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102941

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel